Cabaletta Bio, Inc.
CABA
$2.75
$0.041.48%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -11.72% | -5.29% | 5.83% | 23.51% | 33.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.78% | 33.64% | 37.64% | 42.72% | 49.69% |
| Operating Income | -23.78% | -33.64% | -37.64% | -42.72% | -49.69% |
| Income Before Tax | -25.67% | -38.39% | -44.87% | -52.19% | -60.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -25.67% | -38.39% | -44.87% | -52.19% | -60.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.67% | -38.39% | -44.87% | -52.19% | -60.35% |
| EBIT | -23.78% | -33.64% | -37.64% | -42.72% | -49.69% |
| EBITDA | -24.38% | -34.32% | -38.21% | -43.15% | -50.11% |
| EPS Basic | 42.20% | 22.84% | 2.53% | -17.76% | -42.44% |
| Normalized Basic EPS | 42.20% | 22.85% | 2.53% | -17.76% | -42.44% |
| EPS Diluted | 42.21% | 22.92% | 2.72% | -17.50% | -42.20% |
| Normalized Diluted EPS | 42.20% | 22.85% | 2.53% | -17.76% | -42.44% |
| Average Basic Shares Outstanding | 121.58% | 90.68% | 61.17% | 36.87% | 12.82% |
| Average Diluted Shares Outstanding | 121.58% | 90.68% | 61.17% | 36.87% | 12.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |